Comparative Pharmacology
Head-to-head clinical analysis: GAMOPHEN versus READYPREP CHG.
Peer-Reviewed Evidence
Head-to-head clinical analysis: GAMOPHEN versus READYPREP CHG.
GAMOPHEN vs READYPREP CHG
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Gamophen contains chlorhexidine gluconate, a cationic bisbiguanide that disrupts microbial cell membranes by binding to negatively charged phosphate groups on bacterial cell walls, leading to leakage of intracellular contents and cell death. It also inhibits bacterial enzymes and has broad-spectrum antimicrobial activity against gram-positive and gram-negative bacteria, fungi, and some viruses.
Chlorhexidine gluconate disrupts microbial cell membranes, causing leakage of cytoplasmic contents and cell death. Its cationic nature binds to negatively charged bacterial cell walls, providing persistent antimicrobial activity.
GAMOPHEN is not a recognized pharmaceutical drug. Please verify the drug name.
No standard systemic dosing; used as a 4% chlorhexidine gluconate topical antiseptic solution applied once daily to entire body for preoperative skin preparation or for chlorhexidine bathing in infection prevention protocols.
None Documented
None Documented
Terminal elimination half-life is 18-32 hours in adults, prolonged in renal impairment (up to 60 hours in severe cases).
60 minutes (terminal) in patients with normal renal function; prolonged in renal impairment.
Primarily renal excretion of unchanged drug (50-70%) and glucuronide conjugates; biliary/fecal elimination accounts for <10%.
Renal: ~100% unchanged via glomerular filtration. No biliary or fecal elimination.
Category C
Category C
Antiseptic
Antiseptic